Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02569424
Other study ID # CHU-0246
Secondary ID 2015-A00606-43
Status Completed
Phase N/A
First received September 24, 2015
Last updated December 2, 2016
Start date September 2015
Est. completion date December 2016

Study information

Verified date December 2016
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.

In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.

The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.


Description:

There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.

In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.

The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Any patient ventilated in intensive care is eligible.

- Age = 18 years

- Patient with stable hemodynamic status and Mean Blood Pressure (< 65 mmHg)

- Patient with registered social security number

Exclusion Criteria:

- clinical sign for a central venous thrombosis (unilateral edema ...).during echography screening before inclusion

- presence of a central line for more than 48 hours.

- Anechoic patient (checked during echography screening)

- History of cervical spine surgery.

- IntraCranial HyperTension

- patient in shock with hemodynamic instability and not stabilized

- patient treated by noradrenaline > 1 µg/kg/min

- patient or relative's refusal

- protected patients = 18 years, minors, pregnant women

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Management of the Expiratory End-expiratory Pressure (PEEP) and Body Position
  • Ventilated Patient in Intensive Care

Intervention

Behavioral:
Patient's position
Supine or Trendelenburg strict -20°)

Locations

Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The cross-sectional area of the jugular veins ( in cm2) The cross-sectional area of the jugular veins ( in cm2) at the end of the intervention at baseline No
Secondary The cross-sectional area of the subclavian veins ( in cm2) The cross-sectional area of the subclavian veins ( in cm2) at the end of the intervention at baseline No
Secondary The antero-posterior diameter of the jugular veins (in mm) The antero-posterior diameter of the jugular veins (in mm) at the end of the intervention at baseline No
Secondary The antero-posterior diameter of the subclavian veins (in mm) The antero-posterior diameter of the subclavian veins (in mm) at the end of the intervention at baseline No
Secondary The distance between posterior and pleural lining of the jugular veins (in mm) The distance between posterior and pleural lining of the jugular veins (in mm) at the end of the intervention at baseline No
Secondary The distance between posterior and pleural lining of the subclavian veins (in mm) The distance between posterior and pleural lining of the subclavian veins (in mm) at the end of the intervention at baseline No